Basic Information
LncRNA/CircRNA Name | TUSC7 |
Synonyms | TUSC7, LINC00902, LSAMP-AS1, LSAMP-AS3, LSAMPAS3, NCRNA00295 |
Region | GRCh38_3:116709235-116723581 |
Ensemble | ENSG00000243197 |
Refseq | NR_015391 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | colorectal cancer |
ICD-0-3 | C19.9 |
Methods | qPCR etc. |
Sample | colorectal cancer cell lines (HT29, SW480, SW620, DLD-1) |
Expression Pattern | down-regulated |
Function Description | In this study, we indicated that the expression of TUSC7 was downregulated in colorectal cancer cell lines and tissues. Moreover, the expression of TUSC7 was lower in the high-grade (Dukes C and D) colorectal cancer patients compared to that in the low-grade colorectal cancer patients (Dukes A and B). Colorectal cancer patients with a lower level of TUSC7 expression had worse overall survival rate. In addition, we demonstrated that overexpression of TUSC7 inhibited the expression of miR-10a and enhanced the expression of PTEN and EphA8, which were the direct target genes of miR-10a.The colorectal cancer patients with lower TUSC7 expression had worse overall survival rate compared with those with high TUSC7 expression.Increasing studies suggested that lncRNA played as a ceRNA to modulate miRNAs in tumor development |
Pubmed ID | 28979678 |
Year | 2017 |
Title | TUSC7 acts as a tumor suppressor in colorectal cancer. |
External Links
Links for TUSC7 | GenBank HGNC NONCODE |
Links for colorectal cancer | OMIM COSMIC |